{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:30:28Z","timestamp":1793089828194,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA33572"],"award-info":[{"award-number":["P30CA33572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008307","name":"Beckman Research Institute, City of Hope","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-22-1-0331"],"award-info":[{"award-number":["W81XWH-22-1-0331"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["HT9425-25-1-0500"],"award-info":[{"award-number":["HT9425-25-1-0500"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-16-1-0641"],"award-info":[{"award-number":["W81XWH-16-1-0641"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbcan.2025.189396","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:51:36Z","timestamp":1753141896000},"page":"189396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics"],"prefix":"10.1016","volume":"1880","author":[{"given":"Pankaj","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gargi","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Salgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad S.","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.bbcan.2025.189396_bb0005","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review","volume":"13","author":"Lukasiewicz","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189396_bb0010","first-page":"281","article-title":"Molecular subtypes and imaging phenotypes of breast cancer","volume":"35","author":"Cho","year":"2016","journal-title":"Ultrasonography (Seoul, Korea)"},{"key":"10.1016\/j.bbcan.2025.189396_bb0015","series-title":"Breast Cancer [Internet]","article-title":"Subtypes of breast cancer","author":"Orrantia-Borunda","year":"2022"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0020","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.18632\/oncotarget.12284","article-title":"Triple-negative breast cancer: is there a treatment on the horizon?","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2025.189396_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189396_bb0030","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/pharmaceutics14061303","article-title":"Metabolic reprogramming in cancer cells: emerging molecular mechanisms and novel therapeutic approaches","volume":"14","author":"Navarro","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbcan.2025.189396_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","article-title":"Metabolic adaptation in hypoxia and cancer","volume":"502","author":"Paredes","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189396_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejca.2022.11.025","article-title":"Metabolic switch in cancer - survival of the fittest","volume":"180","author":"Raskov","year":"2023","journal-title":"Europ. J. Cancer (Oxford, England: 1990)"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189396_bb0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","article-title":"Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark. Res."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189396_bb0055","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","article-title":"Emerging therapies in cancer metabolism","volume":"35","author":"Xiao","year":"2023","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189396_bb0060","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189396_bb0065","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/cancers16030504","article-title":"Metabolic signature of Warburg effect in cancer: an effective and obligatory interplay between nutrient transporters and catabolic\/anabolic pathways to promote tumor growth","volume":"16","author":"Mathew","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189396_bb0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189396_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.577420","article-title":"Alterations of lipid metabolism in cancer: implications in prognosis and treatment","volume":"10","author":"Fern\u00e1ndez","year":"2020","journal-title":"Front. Oncol."},{"issue":"7947","key":"10.1016\/j.bbcan.2025.189396_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-05661-6","article-title":"Slow TCA flux and ATP production in primary solid tumors but not metastases","volume":"614","author":"Bartman","year":"2023","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189396_bb0085","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189396_bb0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fonc.2020.00428","article-title":"Metabolic reprogramming in triple-negative breast Cancer","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189396_bb0095","doi-asserted-by":"crossref","first-page":"1113739","DOI":"10.3389\/fnut.2023.1113739","article-title":"Lactate in the tumor microenvironment: a rising star for targeted tumor therapy","volume":"10","author":"Li","year":"2023","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12964-023-01178-1","article-title":"The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape","volume":"21","author":"Zipinotti Dos Santos","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189396_bb0105","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.7150\/ijbs.92125","article-title":"Reprogramming of lipid metabolism mediates crosstalk, remodeling, and intervention of microenvironment components in breast cancer","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2025.189396_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115464","article-title":"Glutamine metabolism in breast cancer and possible therapeutic targets","volume":"210","author":"Li","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"34","key":"10.1016\/j.bbcan.2025.189396_bb0115","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1038\/s41388-022-02408-5","article-title":"Glutamine addiction promotes glucose oxidation in triple-negative breast cancer","volume":"41","author":"Quek","year":"2022","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189396_bb0120","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/ol.2012.928","article-title":"Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (review)","volume":"4","author":"Zheng","year":"2012","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189396_bb0125","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189396_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/imm.12777","article-title":"Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes","volume":"152","author":"Allison","year":"2017","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189396_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.humimm.2022.01.014","article-title":"The acidic tumor microenvironment: manipulating the immune response to elicit escape","volume":"83","author":"Worsley","year":"2022","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189396_bb0140","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/apm.13447","article-title":"Unraveling the intricacies of cancer-associated fibroblasts: a comprehensive review on metabolic reprogramming and tumor microenvironment crosstalk","volume":"132","author":"Ahuja","year":"2024","journal-title":"APMIS"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189396_bb0145","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/genes15070903","article-title":"A comprehensive review of HER2 in cancer biology and therapeutics","volume":"15","author":"Cheng","year":"2024","journal-title":"Genes"},{"issue":"61","key":"10.1016\/j.bbcan.2025.189396_bb0150","first-page":"1","article-title":"Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment","volume":"24","author":"Wan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189396_bb0155","article-title":"The metabolic mechanisms of breast cancer metastasis","volume":"10","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189396_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.31083\/j.fbl2903099","article-title":"The molecular mechanisms behind advanced breast cancer metabolism: Warburg effect, OXPHOS, and calcium","volume":"29","author":"Mitaishvili","year":"2024","journal-title":"Front. Biosci. (Landmark Edition)"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189396_bb0165","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/cancers17040650","article-title":"Lipid metabolism in breast cancer: from basic research to clinical application","volume":"17","author":"Huang","year":"2025","journal-title":"Cancers"},{"issue":"20","key":"10.1016\/j.bbcan.2025.189396_bb0170","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.3390\/molecules25204831","article-title":"Targeting metabolism in cancer cells and the tumor microenvironment for cancer therapy","volume":"25","author":"Li","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189396_bb0175","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/ijms18122755","article-title":"Metabolic pathways of the Warburg effect in health and disease: perspectives of choice, chain or chance","volume":"18","author":"Burns","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189396_bb0180","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cac2.12549","article-title":"The regulatory roles and clinical significance of glycolysis in tumor","volume":"44","author":"Qiao","year":"2024","journal-title":"Cancer Commun. (Lond. England)"},{"key":"10.1016\/j.bbcan.2025.189396_bb0185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189396_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185092","article-title":"Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition","volume":"12","author":"Lampa","year":"2017","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.bbcan.2025.189396_bb0195","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-24-0254","article-title":"Therapeutic targeting of the GLS1-c-Myc positive feedback loop suppresses Glutaminolysis and inhibits progression of head and neck cancer","volume":"84","author":"Yang","year":"2024","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189396_bb0200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3892\/ijo.2020.5158","article-title":"Serine, glycine and one-carbon metabolism in cancer (review)","volume":"58","author":"Pan","year":"2021","journal-title":"Int. J. Oncol."},{"issue":"Suppl","key":"10.1016\/j.bbcan.2025.189396_bb0205","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.semcancer.2015.02.006","article-title":"Sustained proliferation in cancer: mechanisms and novel therapeutic targets","volume":"35 Suppl","author":"Feitelson","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189396_bb0210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4331\/wjbc.v6.i3.148","article-title":"Metabolic interplay between glycolysis and mitochondrial oxidation: the reverse Warburg effect and its therapeutic implication","volume":"6","author":"Lee","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189396_bb0215","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.phrs.2015.06.013","article-title":"Mitochondrial ROS and cancer drug resistance: implications for therapy","volume":"100","author":"Okon","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189396_bb0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/antiox14020201","article-title":"Oxidative stress and reprogramming of lipid metabolism in cancers","volume":"14","author":"Li","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbcan.2025.189396_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.763902","article-title":"Recent metabolomics analysis in tumor metabolism reprogramming","volume":"8","author":"Han","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbcan.2025.189396_bb0230","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-3-031-70875-6_17","article-title":"Metabolic reprogramming and adaption in breast cancer progression and metastasis","volume":"1464","author":"Zuo","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189396_bb0235","doi-asserted-by":"crossref","first-page":"9125","DOI":"10.3390\/ijms21239125","article-title":"Cancer stem cell-associated pathways in the metabolic reprogramming of breast cancer","volume":"21","author":"El-Sahli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189396_bb0240","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/cells14100717","article-title":"The metabolic landscape of cancer stem cells: insights and implications for therapy","volume":"14","author":"Milella","year":"2025","journal-title":"Cells"},{"issue":"34","key":"10.1016\/j.bbcan.2025.189396_bb0245","doi-asserted-by":"crossref","first-page":"35141","DOI":"10.18632\/oncotarget.6177","article-title":"Metabolic plasticity of cancer stem cells","volume":"6","author":"Luo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2025.189396_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116498","article-title":"Gynecological cancer tumor microenvironment: unveiling cellular complexity and therapeutic potential","volume":"229","author":"Garg","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0255","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","article-title":"The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment","volume":"21","author":"Emami Nejad","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189396_bb0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/ph17020195","article-title":"Targeting hypoxia-inducible Factor-1 (HIF-1) in Cancer: emerging therapeutic strategies and pathway regulation","volume":"17","author":"Qannita","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbcan.2025.189396_bb0265","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","article-title":"Lactate in the regulation of tumor microenvironment and therapeutic approaches","volume":"9","author":"de la Cruz-L\u00f3pez","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189396_bb0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Sig. Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7150\/thno.103376","article-title":"Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer","volume":"15","author":"Jiang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189396_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.800630","article-title":"Indoleamine 2,3-dioxygenase 1: a promising therapeutic target in malignant tumor","volume":"12","author":"Song","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0285","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189396_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: from immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189396_bb0295","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/cancers16132478","article-title":"Emerging therapeutic strategies to overcome drug resistance in cancer cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189396_bb0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0305","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/ijms21010234","article-title":"2-deoxy-d-glucose and its analogs: from diagnostic to therapeutic agents","volume":"21","author":"Pajak","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189396_bb0310","first-page":"151","article-title":"Mechanism of antineoplastic activity of lonidamine","volume":"1866","author":"Nath","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2025.189396_bb0315","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2020.12.038","article-title":"Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models","volume":"502","author":"Wicker","year":"2021","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189396_bb0320","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/bcp.12958","article-title":"The therapeutic potential of mTOR inhibitors in breast cancer","volume":"82","author":"Steelman","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189396_bb0325","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1158\/1541-7786.MCR-23-0049","volume":"21","author":"Jiang","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189396_bb0330","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1158\/0008-5472.CAN-22-1029","volume":"83","author":"Jiang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189396_bb0335","article-title":"Cancer biomarkers and precision oncology: a review of recent trends and innovations. Clinical medicine insights","volume":"18","author":"AlDoughaim","year":"2024","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-024-02205-6","article-title":"Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189396_bb0345","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s12282-023-01502-0","article-title":"Glutaminase (GLS1) gene expression in primary breast cancer","volume":"30","author":"Vidula","year":"2023","journal-title":"Breast Cancer (Tokyo, Japan)"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189396_bb0350","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/fon.10.11","article-title":"Fatty acid synthase as a potential therapeutic target in cancer","volume":"6","author":"Flavin","year":"2010","journal-title":"Future Oncol. (London, England)"},{"key":"10.1016\/j.bbcan.2025.189396_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116850","article-title":"Strategic advancements in targeting the PI3K\/AKT\/mTOR pathway for breast cancer therapy","volume":"236","author":"Garg","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189396_bb0360","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189396_bb0365","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.3390\/cancers14194568","article-title":"Targeting glucose metabolism enzymes in Cancer treatment: current and emerging strategies","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0370","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189396_bb0375","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3390\/cancers15072043","article-title":"Metabolic interventions in tumor immunity: focus on dual pathway inhibitors","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189396_bb0380","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/cancers12040862","article-title":"Metabolic heterogeneity of Cancer cells: an interplay between HIF-1, GLUTs, and AMPK","volume":"12","author":"Moldogazieva","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189396_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1114582","article-title":"The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment","volume":"14","author":"Keerthana","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189396_bb0390","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9836256","article-title":"Onco-multi-OMICS approach: a new frontier in cancer research","volume":"2018","author":"Chakraborty","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189396_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119266","article-title":"Proteomics approaches to characterize the immune responses in cancer","volume":"1869","author":"Urbiola-Salvador","year":"2022","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189396_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103798","article-title":"Machine learning for multi-omics data integration in cancer","volume":"25","author":"Cai","year":"2022","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189396_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189026","article-title":"Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers","volume":"1878","author":"Garg","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189396_bb0410","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3390\/ijms23042170","article-title":"Fatty acid metabolism in ovarian cancer: therapeutic implications","volume":"23","author":"Yoon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189396_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114526","article-title":"Metabolic reprogramming and interventions in endometrial carcinoma","volume":"161","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189396_bb0420","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.3390\/cancers14092220","article-title":"Tumor-associated macrophages and ovarian cancer: implications for therapy","volume":"14","author":"Schweer","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0425","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2015.12.030","article-title":"Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine","volume":"141","author":"Zamarin","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189396_bb0430","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/polym15071596","article-title":"Nanoparticles as drug delivery systems: a review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems","volume":"15","author":"Yusuf","year":"2023","journal-title":"Polymers"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189396_bb0435","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/cancers13040762","article-title":"Linking metabolic reprogramming, plasticity and tumor progression","volume":"13","author":"Shuvalov","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189396_bb0440","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/cancers15061899","article-title":"Cancer-associated fibroblasts: master tumor microenvironment modifiers","volume":"15","author":"Wright","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189396_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216396","article-title":"Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy","volume":"575","author":"Luo","year":"2023","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189396_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189106","article-title":"Emerging biomarkers and molecular targets for precision medicine in cervical cancer","volume":"1879","author":"Garg","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189396_bb0455","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.csbj.2021.01.009","article-title":"Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis","volume":"19","author":"Menyh\u00e1rt","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189396_bb0460","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189396_bb0465","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1186\/s12951-024-03005-2","article-title":"Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy","volume":"22","author":"Feng","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189396_bb0470","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10555-023-10113-2","article-title":"New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions","volume":"42","author":"Zhang","year":"2023","journal-title":"Cancer Metastasis Rev."},{"issue":"22","key":"10.1016\/j.bbcan.2025.189396_bb0475","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.3390\/cancers16223884","article-title":"Artificial intelligence\u2013driven computational approaches in the development of anticancer drugs","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T21:12:22Z","timestamp":1758143542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25001386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0304419X25001386"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189396","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189396"}}